Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD) is a mental health condition marked by persistent and excessive worry about various aspects of life, often leading to physical symptoms and difficulty in daily functioning.
Generalized Anxiety Disorder: MM120 Medication Study
We are testing a new oral medication, MM120, to see if it helps reduce anxiety symptoms in adults with generalized anxiety disorder. The study will also look at its effects on quality of life and sexual functioning.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 74 years old?
- Do you have a diagnosis of Generalized Anxiety Disorder (GAD)?
- Are you currently pregnant or breastfeeding?
- Have you had any major surgery or trauma in the last 3 months?
- Are you taking any medications for serious health conditions like heart disease or severe mental health issues?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Lysergide
MM120
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
A-Shine s.r.o.
Pilsen, Czechia
Clintrial s.r.o.
Prague, Czechia
INEP medical s.r.o.
Prague, Czechia
Sponsor: Mind Medicine Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.